LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia
; 33(6): 1501-1513, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30607021
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Leukemia, Myeloid, Acute
/
Biomarkers, Tumor
/
Gene Expression Regulation, Neoplastic
/
Lysosomal-Associated Membrane Protein 2
/
Antimetabolites, Antineoplastic
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
France